The global DNA & RNA banking services market size is expected to reach USD 9.29 billion by 2028 according to a new study by Polaris Market Research. The report “DNA & RNA Banking Services Market Share, Size, Trends, Industry Analysis Report, By Service (Transportation, Processing, Storage, Quality Control, Data Storage, Others); By Specimen (Blood, Buccal Swabs & Hair Follicles, Others); By Application; By End-Use, By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
In 2020, the drug discovery market segment of DNA & RNA banking services held the largest share. This high market share is attributed to research on biomarker discovery, scientific progressions in clinical research, and the rising need for drug discovery processes. These banking services support the entire therapy monitoring, disease prevention, and appropriate diagnosis with proper follow-ups.
The improving paradigm shift towards treatment by personalized medicine has further favored the market growth. It involves epi-genomics, proteomics, and metabolomics, which uses DNA and RNA samples for new treatment procedures. These biobanks provide data related to gene correlations to decipher any form of genetic variations.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/dna-rna-banking-services-market/request-for-sample
The therapeutics segment is projected to witness a lucrative market growth over the DNA & RNA banking services study period. This is primarily due to large-scale government-sponsored immunization programs and a surge in infectious diseases, over the past decade. In addition, the increasing demand for storage is expected to propel market growth for DNA & RNA banking services.
This has created enormous opportunities for these data banks for future research on infectious diseases, and immunity pathways. For instance, Oxford Vaccine Center collects both RNA and DNA samples to offer data insights related to infectious diseases, resulting in driving the market growth for the DNA & RNA banking services.
Market participants operating in the DNA & RNA banking services industry include EasyDNA, 23andMe, Inc., GoodCell, ProteoGenex, LGC Biosearch Technologies, DNA Genotek Inc., US Biolab Corporation, Inc., Thermo Fisher Scientific, Inc., deCODE genetics, Infinity Biologix, Brooks Life Sciences, and PreventionGenetics.
Polaris Market Research has segmented the DNA & RNA banking services market report on the basis of service type, specimen type, application, end use, and region:
DNA & RNA Banking Services, Service Type Outlook (Revenue – USD Million, 2016 – 2028)
- Transportation Service
- Processing Service
- Storage Service
- Quality Control Service
- Data Storage
DNA & RNA Banking Services, Specimen Type Outlook (Revenue – USD Million, 2016 – 2028)
- Buccal Swabs & Hair Follicles
DNA & RNA Banking Services, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
DNA & RNA Banking Services, End Use Outlook (Revenue – USD Million, 2016 – 2028)
- Academic Research
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
DNA & RNA Banking Services, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Central & South America
- Middle East & Africa
- Saudi Arabia
- South Africa